WebAug 10, 2024 · WALTHAM, Mass., August 10, 2024 – Dyne Therapeutics , a biotechnology company focused on developing life-transforming therapies for patients with serious muscle diseases, today announced the closing of a $115 million equity financing led by new investors Vida Ventures and Surveyor Capital (a WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.
Dyne Therapeutics Announces $115 Million Financing to Advance …
WebDyne Therapeutics is a biotechnology company which offers targeted therapies for patients with cardiac diseases, and serious and smooth muscle diseases. The Company … WebSep 6, 2024 · The Company will review its pipeline with a focus on the clinical programs and opportunity for DYNE-101 in myotonic dystrophy type 1 (DM1) and DYNE-251 in DMD and be joined by leading neuromuscular disease experts. The event will feature presentations, discussion and Q&A with the following speakers: ... About Dyne … green salad with fruit and nuts
Dyne Therapeutics Announces Initiation of Phase 1/2 ACHIEVE …
WebMar 23, 2024 · Dyne Therapeutics, Inc. today announced that DYNE-251 was granted U.S. Food and Drug Administration (FDA) orphan drug and rare pediatric disease designations. ... Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a … WebJan 18, 2024 · Dyne will work closely with the FDA to resolve the clinical hold as promptly as possible. As previously announced, the Company expects to submit an IND for DYNE-101 in myotonic dystrophy type 1 (DM1) during the first quarter of 2024 and to be dosing patients in a planned MAD clinical trial by mid-2024. About Dyne Therapeutics WebJan 18, 2024 · Dyne Therapeutics (DYN-5.97%) saw its shares slump 18.1% on Tuesday. The biotech stock closed on Friday at $9.29 a share, then opened on Tuesday at $7.82, falling to a new 52-week low of $7.61 in ... green salad with craisins